San Francisco, California – Immumem Therapeutics, a biotechnology company pioneering next-generation cell therapies for refractory solid tumors, today announced it has secured backing from LvlUp Ventures’ LvlUp Labs- a non-equity startup program. The funding and strategic support will accelerate Immumem’s mission to rebuild the foundational infrastructure of oncology treatments by combining allogeneic iPSC-derived memory T … Continue reading Immumem Therapeutics Announces Backing from LvlUp Ventures’ LvlUp Labs Program to Eradicate Cancer Relapse Using AI-Driven, iPSC-Derived Cell Therapies